Willingness to pay for over-the-counter self-medication for the primary prevention of myocardial infarction
- At: 2008 FIP Congress in Basel (Switzerland)
- Type: Poster
- By: HASHIGUCHI, Masayuki (Keio University, Tokyo, Japan)
- Co-author(s): Matsumoto, Ryo (Kanto Chuo Hospital, Japan)
Watanabe, Noriaki (Kitasato Institute Hospital, Japan)
Mochizuki, Mayumi (Keio University, TOKYO, Japan)
Background: Today, cardiovascular disease (CVD) is the second leading cause of death in Japan, and the economic impact of CVD in the national medical expenditure cannot be disregarded. As HMG-CoA reductase inhibitors (i.e., statins) are known to reduce the risk of CVD, simvastatin is sold in the UK as over-the-counter (OTC) medication. The.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.